Cti Biopharma Corp Stock Price To Book
| CTICDelisted Stock | USD 9.09 0.00 0.00% |
CTi Biopharma Corp fundamentals help investors to digest information that contributes to CTi Biopharma's financial success or failures. It also enables traders to predict the movement of CTi Stock. The fundamental analysis module provides a way to measure CTi Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CTi Biopharma stock.
CTi |
CTi Biopharma Corp Company Price To Book Analysis
CTi Biopharma's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current CTi Biopharma Price To Book | 112.63 X |
Most of CTi Biopharma's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CTi Biopharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, CTi Biopharma Corp has a Price To Book of 112 times. This is 338.6% higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The price to book for all United States stocks is notably lower than that of the firm.
CTi Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CTi Biopharma's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CTi Biopharma could also be used in its relative valuation, which is a method of valuing CTi Biopharma by comparing valuation metrics of similar companies.CTi Biopharma is currently under evaluation in price to book category among its peers.
CTi Fundamentals
| Return On Equity | -10.19 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.91) % | |||
| Operating Margin | (0.74) % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 131.88 M | |||
| Shares Owned By Insiders | 5.49 % | |||
| Shares Owned By Institutions | 83.28 % | |||
| Number Of Shares Shorted | 11.27 M | |||
| Price To Earning | (1.68) X | |||
| Price To Book | 112.63 X | |||
| Price To Sales | 22.01 X | |||
| Revenue | 53.95 M | |||
| Gross Profit | 50.43 M | |||
| EBITDA | (79.85 M) | |||
| Net Income | (92.99 M) | |||
| Cash And Equivalents | 81.64 M | |||
| Cash Per Share | 0.64 X | |||
| Total Debt | 49.96 M | |||
| Current Ratio | 3.26 X | |||
| Book Value Per Share | (0.19) X | |||
| Cash Flow From Operations | (81.19 M) | |||
| Short Ratio | 1.08 X | |||
| Earnings Per Share | (0.54) X | |||
| Target Price | 10.05 | |||
| Number Of Employees | 127 | |||
| Beta | 0.83 | |||
| Market Capitalization | 1.2 B | |||
| Total Asset | 125.92 M | |||
| Retained Earnings | (2.52 B) | |||
| Working Capital | 18.26 M | |||
| Current Asset | 134.97 M | |||
| Current Liabilities | 72.41 M | |||
| Z Score | -15.1 | |||
| Net Asset | 125.92 M |
About CTi Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CTi Biopharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CTi Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CTi Biopharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |